PharmaShots | Article | PharmaShots Interview: Cartesian Therapeutics’s Dr. Murat Kalayoglu Shares Insight on RNA Cell Therapy for an Autoimmune Disease |
Washington Business Journal | Article | Gaithersburg is evolving gradually, with several new projects in the works. Join us on a tour. |
Technology Networks | Article | Innovating Reversible Cell Therapies With RNA |
Pharmaceutical Executive | Article | The New COVID Workforce: Keeping Pharma Strong Through Adversity |
DNAweekly | Article | Exploring RNA-Based Oncology Treatments With Cartesian Therapeutics |
BioSpace | Article | Carting Away Problematic Cells with CAR-T Therapy for Myasthenia Gravis
|
GEN | Article | Building a Bioprocess for RNA-Based Therapies |
Fierce Biotech | Brief | Chutes & Ladders—FDA’s vaccine office gets new leader as 2 officials head toward exit |
BioSpace | Brief | BioSpace Movers & Shakers, Oct. 1 |
PharmTech Focus | Article | Cartesian Therapeutics Strengthens Leadership Team With Hire of Miloš Miljković, M.D., as Chief Medical Officer |
Washington Business Journal | Article | Gaithersburg biopharma prepares to double footprint, headcount |
BioWorld | Brief | Appointments and advancements for Sept. 28, 2021 |
Gene Therapy Live | Video | RNA-Modified vs DNA-Modified CAR T Products |
Myasthenia Gravis News | Article | CAR T-cell Therapy Descartes-08 Eased MG Symptoms |
Cell & Gene | Podcast | State-of-the-Art GMP Manufacturing RNA Cell Therapies With Cartesian’s CEO |
Life Science Leader | Article | Implementing GMP For Early-Phase Development With Cartesian Therapeutics Co-Founder And CEO, Dr. Murat Kalayoglu |
Clinical Leader | Article | No CMOs Or CROs: A Unique Approach To Cell Therapy Development |
RARECAST | Podcast | Episode #342 – Overcoming the Limitations of Conventional Cell Engineering |
BioProcess Online | Article | GMP Manufacturing Of RNA-Engineered Cell Therapies |
BioTalk | Podcast | Murat Kalayoglu, MD, PhD – Cartesian Therapeutics (EP.89) |
Clinical Trials Arena | Article | Cartesian: pioneering RNA-engineered cell therapy in cancer and beyond |
Contagion Live | Article + Video | RNA Cell Therapy for COVID-19 Related ARDS in Development |
Business of Biotech | Podcast | RNA-Engineered Cell Therapy With Cartesian’s Dr. Murat Kalayoglu |
Cell & Gene | Article | RNA Cell Therapy: A New Class of Advanced Therapies |
Health Professional Radio | Podcast | Cartesian-Therapeutics-–-Pioneering-mRNA-Engineered-Cell-Therapy |
Healio | Article | The case for CAR T cells as earlier treatment requires more evidence |
GEN | Panel | CAR-T Therapy: Working with a Manufacturing Partner |
Informa | Panel | Pandemic Perspectives: R&D Lessons Learned from the COVID Year |
DocWire News | Video Interview | Dr. Murat Kalayoglu Discusses New Frontline Therapy Treatment for Multiple Myeloma |
OncLive | Article | mRNA-Based CAR T-Cell Therapy Descartes-11 Moves Into Phase 2 Trial in Myeloma |
Cancer Therapy Advisor | Article | Descartes-11 Trial Tests RNA-Engineer Cell Therapy in Multiple Myeloma |
Precision Oncology News | Article | Cartesian Therapeutics Bets on mRNA Engineering for Moving CAR T Cells Into Frontline Treatment |
CURE | Article | Cartesian Therapeutics Bets on mRNA Engineering for Moving CAR T Cells Into Frontline Treatment |